PL1844008T3 - Krystaliczne sole walnemuliny z kwasami organicznymi - Google Patents
Krystaliczne sole walnemuliny z kwasami organicznymiInfo
- Publication number
- PL1844008T3 PL1844008T3 PL06706426T PL06706426T PL1844008T3 PL 1844008 T3 PL1844008 T3 PL 1844008T3 PL 06706426 T PL06706426 T PL 06706426T PL 06706426 T PL06706426 T PL 06706426T PL 1844008 T3 PL1844008 T3 PL 1844008T3
- Authority
- PL
- Poland
- Prior art keywords
- valnemulin
- organic acids
- crystalline salts
- crystalline
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/24—Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
- C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
- C07C2603/82—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05001498A EP1686115A1 (de) | 2005-01-26 | 2005-01-26 | Organische Säureadditionssalze von Valnemulin |
PCT/EP2006/000680 WO2006079535A1 (en) | 2005-01-26 | 2006-01-26 | Valnemulin salts with organic acids |
EP06706426A EP1844008B1 (en) | 2005-01-26 | 2006-01-26 | Valnemulin crystalline salts with organic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1844008T3 true PL1844008T3 (pl) | 2011-01-31 |
Family
ID=34933446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06706426T PL1844008T3 (pl) | 2005-01-26 | 2006-01-26 | Krystaliczne sole walnemuliny z kwasami organicznymi |
Country Status (21)
Country | Link |
---|---|
US (1) | US20090156674A1 (pl) |
EP (2) | EP1686115A1 (pl) |
JP (1) | JP4922948B2 (pl) |
KR (1) | KR101354738B1 (pl) |
CN (1) | CN101107224B (pl) |
AR (1) | AR052468A1 (pl) |
AT (1) | ATE476415T1 (pl) |
AU (1) | AU2006208642B2 (pl) |
BR (1) | BRPI0607271A2 (pl) |
CA (1) | CA2594582C (pl) |
DE (1) | DE602006015909D1 (pl) |
DK (1) | DK1844008T3 (pl) |
ES (1) | ES2349757T3 (pl) |
MX (1) | MX2007008975A (pl) |
NZ (1) | NZ555895A (pl) |
PL (1) | PL1844008T3 (pl) |
PT (1) | PT1844008E (pl) |
RU (1) | RU2401256C2 (pl) |
TW (1) | TWI370115B (pl) |
WO (1) | WO2006079535A1 (pl) |
ZA (1) | ZA200704733B (pl) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2411747C2 (ru) * | 2008-12-25 | 2011-02-20 | Сергей Петрович Воронин | Биодоступная форма микроэлементных добавок в кормовые смеси для животных и птиц |
CN101874785A (zh) * | 2010-04-30 | 2010-11-03 | 广东大华农动物食品保健品股份有限公司 | 盐酸沃尼妙林肠溶微丸的配方及其制备方法 |
CN102180818A (zh) * | 2011-03-10 | 2011-09-14 | 青岛科技大学 | 一种延胡索酸沃尼妙林的制备方法 |
CN102225906B (zh) * | 2011-05-12 | 2014-07-30 | 浙江国邦药业有限公司 | 一种沃尼妙林盐酸盐的结晶方法 |
CN102344397B (zh) * | 2011-08-23 | 2013-09-04 | 浙江升华拜克生物股份有限公司 | 一种伐奈莫林盐酸盐的提纯方法 |
CN102813644A (zh) * | 2012-08-07 | 2012-12-12 | 湖北龙翔药业有限公司 | 一种酒石酸沃尼妙林在兽药中的用途 |
CN102813625A (zh) * | 2012-08-29 | 2012-12-12 | 湖北龙翔药业有限公司 | 一种酒石酸沃尼妙林预混剂的制备方法 |
CN102813629A (zh) * | 2012-08-29 | 2012-12-12 | 湖北龙翔药业有限公司 | 一种酒石酸沃尼妙林预混剂的制备方法 |
CN103073464B (zh) * | 2013-02-04 | 2014-11-26 | 中国兽医药品监察所 | 一种富马酸沃尼妙林的制备方法 |
CN103483232B (zh) * | 2013-09-25 | 2015-05-13 | 宁夏泰瑞制药股份有限公司 | 一种盐酸沃尼妙林的精制方法 |
CN103755609B (zh) * | 2014-01-17 | 2016-01-20 | 天津大学 | 酒石酸沃尼妙林的晶型及其制备方法 |
CN104004055A (zh) * | 2014-06-06 | 2014-08-27 | 海南建邦制药科技有限公司 | 胸腺五肽的有机酸盐及其制剂 |
CN104130168B (zh) * | 2014-07-08 | 2016-01-20 | 天津大学 | 一种草酸沃尼妙林晶体及其制备方法 |
CN104230774B (zh) * | 2014-08-26 | 2016-08-17 | 浙江汇能生物股份有限公司 | 一种沃尼妙林盐的纯化方法 |
CN105061273B (zh) * | 2015-07-20 | 2017-04-26 | 中国兽医药品监察所 | 酒石酸沃尼妙林多晶型及其制备方法 |
CN105878228B (zh) * | 2016-06-27 | 2018-05-18 | 河北天元药业有限公司 | 一种延胡索酸泰妙菌素可溶性粉及其制备方法 |
KR101978364B1 (ko) * | 2017-06-15 | 2019-05-14 | 크리스탈지노믹스(주) | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법 |
KR102098289B1 (ko) * | 2018-04-11 | 2020-04-07 | 경북대학교 산학협력단 | 발네물린을 유효성분으로 함유하는 골 질환 예방 또는 치료용 조성물 |
KR102678356B1 (ko) * | 2018-10-29 | 2024-06-26 | 씨지인바이츠 주식회사 | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 인산염, 타르타르산염 또는 이들의 조합을 포함하는 약제학적 조성물 및 그 제조방법 |
CN115645390A (zh) * | 2022-11-04 | 2023-01-31 | 中国兽医药品监察所 | 沃尼妙林有机酸盐类兽药的制备及其在制备治疗家禽气囊炎及猪胸膜肺炎药物中的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3919290A (en) * | 1972-10-03 | 1975-11-11 | Sandoz Ltd | Substituted 14-desoxy-mutilins |
US4032530A (en) * | 1971-10-05 | 1977-06-28 | Sandoz Ltd. | Certain pleuromutilins |
US4086359A (en) * | 1975-09-30 | 1978-04-25 | E. R. Squibb & Sons, Inc. | Derivatives of pleuromutilin and compositions |
EP0153277B1 (de) * | 1984-02-17 | 1987-08-26 | Sandoz Ag | Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
AT400674B (de) * | 1991-07-24 | 1996-02-26 | Biochemie Gmbh | Pharmazeutische pleuromutilin-zubereitung |
AT397654B (de) * | 1992-05-04 | 1994-06-27 | Biochemie Gmbh | Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung |
GB9614017D0 (en) * | 1996-07-04 | 1996-09-04 | Biochemie Gmbh | Organic compounds |
GB0207495D0 (en) * | 2002-03-28 | 2002-05-08 | Biochemie Gmbh | Organic compounds |
GB0218578D0 (en) * | 2002-08-09 | 2002-09-18 | Glaxo Group Ltd | Novel method |
-
2005
- 2005-01-26 EP EP05001498A patent/EP1686115A1/de not_active Withdrawn
-
2006
- 2006-01-24 TW TW095102531A patent/TWI370115B/zh not_active IP Right Cessation
- 2006-01-25 AR ARP060100277A patent/AR052468A1/es not_active Application Discontinuation
- 2006-01-26 AU AU2006208642A patent/AU2006208642B2/en not_active Ceased
- 2006-01-26 ES ES06706426T patent/ES2349757T3/es active Active
- 2006-01-26 DK DK06706426.1T patent/DK1844008T3/da active
- 2006-01-26 PL PL06706426T patent/PL1844008T3/pl unknown
- 2006-01-26 CN CN2006800032951A patent/CN101107224B/zh not_active Expired - Fee Related
- 2006-01-26 AT AT06706426T patent/ATE476415T1/de not_active IP Right Cessation
- 2006-01-26 RU RU2007132258/04A patent/RU2401256C2/ru not_active IP Right Cessation
- 2006-01-26 DE DE602006015909T patent/DE602006015909D1/de active Active
- 2006-01-26 NZ NZ555895A patent/NZ555895A/en not_active IP Right Cessation
- 2006-01-26 PT PT06706426T patent/PT1844008E/pt unknown
- 2006-01-26 EP EP06706426A patent/EP1844008B1/en not_active Not-in-force
- 2006-01-26 WO PCT/EP2006/000680 patent/WO2006079535A1/en active Application Filing
- 2006-01-26 JP JP2007552575A patent/JP4922948B2/ja not_active Expired - Fee Related
- 2006-01-26 US US11/814,868 patent/US20090156674A1/en not_active Abandoned
- 2006-01-26 CA CA2594582A patent/CA2594582C/en not_active Expired - Fee Related
- 2006-01-26 BR BRPI0607271-2A patent/BRPI0607271A2/pt active Search and Examination
- 2006-01-26 MX MX2007008975A patent/MX2007008975A/es active IP Right Grant
- 2006-01-26 KR KR1020077017122A patent/KR101354738B1/ko active IP Right Grant
-
2007
- 2007-06-15 ZA ZA200704733A patent/ZA200704733B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR101354738B1 (ko) | 2014-01-22 |
EP1686115A1 (de) | 2006-08-02 |
KR20070101284A (ko) | 2007-10-16 |
TWI370115B (en) | 2012-08-11 |
DE602006015909D1 (de) | 2010-09-16 |
EP1844008A1 (en) | 2007-10-17 |
JP4922948B2 (ja) | 2012-04-25 |
NZ555895A (en) | 2010-11-26 |
AU2006208642A1 (en) | 2006-08-03 |
WO2006079535A1 (en) | 2006-08-03 |
CA2594582C (en) | 2013-10-08 |
US20090156674A1 (en) | 2009-06-18 |
MX2007008975A (es) | 2007-09-18 |
ES2349757T3 (es) | 2011-01-11 |
ZA200704733B (en) | 2008-09-25 |
DK1844008T3 (da) | 2010-11-15 |
ATE476415T1 (de) | 2010-08-15 |
JP2008528530A (ja) | 2008-07-31 |
AR052468A1 (es) | 2007-03-21 |
RU2007132258A (ru) | 2009-03-10 |
RU2401256C2 (ru) | 2010-10-10 |
TW200637811A (en) | 2006-11-01 |
BRPI0607271A2 (pt) | 2009-08-25 |
EP1844008B1 (en) | 2010-08-04 |
CA2594582A1 (en) | 2006-08-03 |
AU2006208642B2 (en) | 2009-11-26 |
PT1844008E (pt) | 2010-08-31 |
CN101107224A (zh) | 2008-01-16 |
CN101107224B (zh) | 2011-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1844008T3 (pl) | Krystaliczne sole walnemuliny z kwasami organicznymi | |
AP2443A (en) | Crystalline modifications to pyraclostrobin | |
ZA200907414B (en) | Substituted Benzoylamino-indan-2-carboxylic acids and related compounds | |
GB0819182D0 (en) | Crystalline forms | |
IL189895A0 (en) | Triarylcarboxylic acid derivative | |
IL198970A0 (en) | Carboxylic acid derivatives | |
GB0704000D0 (en) | Salts 670 | |
IL199913A0 (en) | Salts 668 | |
HRP20130613T1 (en) | Naphthylacetic acids | |
ZA200904423B (en) | Crystalline forms GLYT 1 | |
DE602007000099D1 (de) | Mähtish mit Antriebsanordnung | |
GB0702459D0 (en) | Salts 669 | |
ZA201102525B (en) | Naphthylacetic acids | |
ZA200903614B (en) | New crystalline forms | |
PT2173710E (pt) | Nova forma cristalina | |
GB0506967D0 (en) | Novel crystalline salt | |
ZA200806859B (en) | Novel crystalline compounds | |
EP1951257A4 (en) | CRYSTALLINE FORMS | |
PL2217781T3 (pl) | Napęd zasuwnicy | |
HU0800755D0 (en) | Novel crystalline forms | |
EP2231588A4 (en) | ORGANIC SALTS OF -ALANINE | |
GB0501567D0 (en) | Crystalline forms | |
GB0523845D0 (en) | Novel salts | |
GB0605195D0 (en) | Starbon acids | |
IL213288A0 (en) | Crystalline forms |